As the Covid-19 vaccine roll-outs continue, employers around the world are making plans for the future of work in a post-pandemic world. As an organisation that has innovation at its core, pharmaceutical giant MSD Ireland has always been future-focused.
Part of a global operation employing 74,000 people worldwide, MSD Ireland is one of this country’s leading healthcare companies, first established here more than half a century ago. That opportunity doesn’t end in Ireland either. “There are numerous examples of Irish employees taking up a varying range of positions with MSD around the world – furthering their careers at a global level.”As part of its continuing investment in Ireland, last year MSD announced the acquisition of a new site in Co Meath, MSD Dunboyne Biologics.
“There’s a strong focus on bringing the right people and skills together within a team to reflect this need for agility, as well as ensuring processes are simplified in order for team members to be flexible and to be empowered to make the right decisions efficiently and effectively.”MSD Dunboyne Biologics runs a ‘Flow to the Work’ model.
“This approach ensures we have all the resources and knowledge we need to make the right decisions on what’s required as we design each unique workday on-site,” she says.MSD Ireland support and accelerate their diverse talent through coaching, mentoring, on-the-job training and learning and development programmes.“Our site is dynamic and fast-paced, and the operations are structured to always be flexible.
“We have a people-first approach to everything, and all teams, at all levels, are structured to champion listening, learning, and developing, be it through formal, structured programmes like our Dunboyne University or through the dynamism of our everyday work. We also support and accelerate our diverse talent through coaching, mentoring, on-the-job training and learning and development programmes. Learning and career development are at the core of everything we do.